Literature DB >> 8985198

Importance of genotypic and phenotypic tolerance in the treatment of experimental endocarditis due to Streptococcus gordonii.

J M Entenza1, I Caldelari, M P Glauser, P Francioli, P Moreillon.   

Abstract

Genotypic and phenotypic tolerance was studied in penicillin treatment of experimental endocarditis due to nontolerant and tolerant Streptococcus gordonii and to their backcross transformants. The organisms were matched for in vitro and in vivo growth rates. Rats with aortic endocarditis were treated for 3 or 5 days, starting 12, 24, or 48 h after inoculation. When started at 12 h, during fast intravegetation growth, 3 days of treatment cured 80% of the nontolerant parent compared with <30% of the tolerant derivative (P < .005). When started at 24 or 48 h and if intravegetation growth had reached a plateau, 3 days of treatment failed against both bacteria. However, a significant difference between the 2 organisms was restored when treatment was extended to 5 days. Thus, genotypic tolerance conferred a survival advantage in both fast- and slow-growing bacteria, demonstrating that the in vitro-defined tolerant phenotype also carried the risk of treatment failure in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985198     DOI: 10.1093/infdis/175.1.70

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Detection of live and antibiotic-killed bacteria by quantitative real-time PCR of specific fragments of rRNA.

Authors:  Steve Aellen; Yok-Ai Que; Bertrand Guignard; Marisa Haenni; Philippe Moreillon
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.

Authors:  A Bizzini; J M Entenza; O Michielin; I Arnold; B Erni; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  2009-10-26       Impact factor: 5.191

3.  Deregulation of the arginine deiminase (arc) operon in penicillin-tolerant mutants of Streptococcus gordonii.

Authors:  I Caldelari; B Loeliger; H Langen; M P Glauser; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

4.  Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii.

Authors:  P Stutzmann Meier; J M Entenza; P Vaudaux; P Francioli; M P Glauser; P Moreillon
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Induction of experimental endocarditis by continuous low-grade bacteremia mimicking spontaneous bacteremia in humans.

Authors:  T R Veloso; M Amiguet; V Rousson; M Giddey; J Vouillamoz; P Moreillon; J M Entenza
Journal:  Infect Immun       Date:  2011-02-14       Impact factor: 3.441

6.  Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis.

Authors:  Tiago Rafael Veloso; Aziz Chaouch; Thierry Roger; Marlyse Giddey; Jacques Vouillamoz; Paul Majcherczyk; Yok-Ai Que; Valentin Rousson; Philippe Moreillon; José Manuel Entenza
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

7.  Y-688, a new quinolone active against quinolone-resistant Staphylococcus aureus: lack of in vivo efficacy in experimental endocarditis.

Authors:  J M Entenza; O Marchetti; M P Glauser; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

8.  Characterization of multi-drug tolerant persister cells in Streptococcus suis.

Authors:  Jörg Willenborg; Daniela Willms; Ralph Bertram; Ralph Goethe; Peter Valentin-Weigand
Journal:  BMC Microbiol       Date:  2014-05-12       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.